objectiveth
major
challeng
use
amniot
fluid
af
cultiv
techniqu
diagnos
microbi
invas
amniot
caviti
miac
sever
day
typic
requir
obtain
result
mani
organ
implic
pathogenesi
human
diseas
difficult
cultur
compar
perform
af
cultur
novel
techniqu
diagnosi
miac
provid
result
within
eight
hour
combin
broadrang
realtim
polymeras
chain
reaction
electrospray
ioniz
mass
spectrometri
pcresim
identifi
quantifi
genom
materi
bacteria
virus
af
methodsaf
sampl
obtain
transabdomin
amniocentesi
women
preterm
labor
ptl
intact
membran
analyz
use
cultiv
techniqu
aerob
anaerob
genit
mycoplasma
well
pcresim
preval
rel
magnitud
intraamniot
inflamm
af
interleukin
concentr
ngml
acut
histolog
chorioamnion
spontan
preterm
deliveri
perinat
mortal
examin
accord
result
two
test
preval
miac
patient
preterm
labor
intact
membran
use
standard
cultiv
techniqu
use
pcresim
seven
ten
patient
posit
af
cultur
also
posit
pcresim
genom
equival
per
pcr
reaction
well
gewel
patient
posit
pcresim
gewel
neg
af
cultur
significantli
higher
rate
intraamniot
inflamm
histolog
acut
chorioamnion
shorter
interv
deliveri
median
interquartil
rangeiqr
offspr
higher
risk
perinat
mortal
women
test
neg
vs
p
vs
iqr
day
vs
iqr
day
ci
respect
signific
differ
factor
patient
posit
pcresim
gewel
neg
af
cultur
compar
posit
af
cultur
pcresim
detect
genom
materi
virus
two
patient
rapid
diagnosi
intraamniot
infect
possibl
use
pcresim
provid
result
within
hour
combin
use
biomark
inflamm
pcresim
allow
rapid
identif
specif
bacteria
virus
women
preterm
labor
intraamniot
infect
approach
may
allow
administr
time
specif
intervent
reduc
morbid
attribut
infectioninduc
preterm
birth
keyword
broadrang
realtim
polymeras
chain
reaction
electrospray
ioniz
mass
spectrometri
intraamniot
inflamm
preterm
deliveri
romero
et
al
preterm
birth
lead
caus
perinat
morbid
mortal
worldwid
microbi
invas
amniot
caviti
miac
determin
cultiv
techniqu
occur
one
everi
four
women
deliv
preterm
yet
may
underestim
sinc
diagnosi
miac
repres
challeng
decad
earli
investig
use
transcerv
cathet
evalu
microbi
state
amniot
caviti
howev
approach
abandon
problem
contamin
thereaft
identif
bacteria
cultiv
techniqu
amniot
fluid
af
retriev
amniocentesi
becam
gold
standard
diagnosi
miac
major
challeng
use
approach
cultur
result
take
sever
day
becom
avail
delay
led
standard
practic
initi
intraven
antimicrobi
agent
patient
posit
gram
stain
indic
inflamm
prior
identifi
microorgan
respons
suspect
infect
latter
assum
inflamm
alway
due
infect
case
rapid
test
result
need
determin
whether
antimicrobi
agent
administ
decis
administr
discontinu
tocolysi
time
deliveri
etc
also
depend
avail
reliabl
inform
presenc
microorgan
amniot
caviti
applic
polymeras
chain
reaction
pcr
base
techniqu
diagnosi
infecti
diseas
provid
result
time
rapid
decisionmak
moreov
techniqu
improv
detect
microorgan
identifi
microb
difficult
cultur
provid
inform
antimicrobi
resist
virul
factor
unknown
whether
techniqu
use
point
care
inform
treatment
decis
obstetr
set
studi
patient
spontan
preterm
labor
ptl
intact
membran
af
cultur
compar
new
techniqu
use
combin
broadrang
realtim
pcr
electrospray
ioniz
mass
spectrometri
pcresim
technolog
techniqu
capabl
identifi
genu
speci
microorgan
af
within
hour
therefor
time
clinic
decis
pcresim
valid
sever
clinic
set
potenti
revolution
detect
infecti
agent
modern
obstetr
studi
object
compar
perform
af
cultur
pcresim
identifi
miac
patient
ptl
intact
membran
assess
magnitud
intraamniot
inflamm
patient
miac
identifi
pcresim
examin
relationship
miac
detect
pcresim
advers
pregnanc
outcom
cohort
studi
conduct
search
clinic
databas
bank
biolog
sampl
wayn
state
univers
detroit
medic
center
perinatolog
research
branch
eunic
kennedi
shriver
nation
institut
child
health
human
develop
nichd
detroit
mi
identifi
patient
diagnosi
spontan
ptl
intact
membran
patient
includ
met
follow
criteria
singleton
gestat
present
ptl
intact
membran
amniocentesi
transabdomin
amniocentesi
perform
week
gestat
microbiolog
studi
patient
exclud
studi
ruptur
chorioamniot
membran
occur
af
collect
chromosom
structur
fetal
anomali
present
perinat
mortal
defin
occurr
fetal
neonat
death
patient
provid
written
inform
consent
use
biolog
specimen
clinic
data
research
purpos
approv
institut
review
board
nichd
wayn
state
univers
patient
preterm
labor
intact
membran
underw
transabdomin
ultrasoundguid
amniocentesi
evalu
possibl
miac
within
standard
care
hutzel
women
hospit
elig
studi
af
immedi
transport
cap
steril
syring
clinic
laboratori
cultur
aerob
anaerob
bacteria
includ
genit
mycoplasma
evalu
white
blood
cell
wbc
count
glucos
concentr
gram
stain
af
also
perform
shortli
collect
af
requir
clinic
assess
centrifug
minut
shortli
amniocentesi
supernat
aliquot
store
analysi
presenc
intraamniot
inflamm
assess
determin
af
concentr
elisa
af
concentr
determin
research
purpos
result
use
patient
manag
af
analyz
use
cultiv
techniqu
aerob
anaerob
genit
mycoplasma
well
pcresim
technolog
athogen
carlsbad
ca
briefli
dna
extract
ul
af
use
method
combin
beadbeat
cell
lysi
magneticbead
base
extract
method
extract
dna
amplifi
bacteri
artifici
chromosom
bac
spectrum
assay
accord
manufactur
instruct
pcresim
identifi
bacteria
candida
spp
repres
platform
signatur
databas
total
extract
kolmogorovsmirnov
test
visual
plot
inspect
use
assess
normal
continu
data
distribut
spearman
nonparametr
correl
coeffici
calcul
kruskalw
mann
whitney
u
test
use
test
differ
arithmet
variabl
distribut
x
fischer
exact
test
use
test
differ
proport
appropri
quantil
regress
model
fit
test
median
differ
adjust
potenti
confound
includ
gestat
age
cervic
dilat
amniocentesi
kaplanmei
surviv
curv
plot
mantelhaenszel
logrank
test
use
test
differ
timetospontan
preterm
deliveri
logist
cox
proport
hazard
regress
model
fit
examin
magnitud
associ
cutoff
classifi
pcresim
result
accord
microbi
inoculum
size
genom
copieswel
sampl
select
upon
inspect
receiv
oper
characterist
roc
curv
identif
intraamniot
inflamm
among
patient
detect
gene
copi
pcresim
analys
twotail
p
valu
consid
signific
spss
spss
chicago
il
use
analyz
data
baselin
characterist
studi
popul
display
tabl
preval
miac
base
posit
af
cultur
pcresim
detect
amplifi
dna
af
sampl
tabl
upon
inspect
roc
curv
identif
intraamniot
inflamm
ngml
among
patient
detect
dna
bacteria
andor
viru
use
pcresim
figur
result
classifi
accord
microbi
burden
posit
neg
posit
test
gewel
wherea
neg
test
fewer
gewel
genom
materi
undetect
figur
show
venn
diagram
describ
combin
result
af
cultur
pcresim
seven
patient
posit
pcresim
ge
well
posit
af
cultur
patient
detect
genom
materi
pcresim
posit
af
cultur
microorgan
identifi
concentr
inflammatori
marker
amniot
fluid
gestat
age
deliveri
well
presenc
absenc
histolog
acut
chorioamnion
shown
tabl
ii
frequent
microorgan
identifi
pcresim
ureaplasma
parvum
instead
ureaplasma
urealyticum
common
microorgan
identifi
standard
af
cultur
fusobacterium
nucleatum
gardnella
vaginali
mycoplasma
homini
acinetobact
junii
detect
pcresim
two
patient
posit
viral
assay
human
enteroviru
use
microbi
inoculum
size
express
gewel
significantli
correl
af
concentr
il
figur
median
af
concentr
significantli
higher
patient
posit
pcresim
result
gewel
neg
af
cultur
among
women
posit
af
cultur
neg
pcresim
result
patient
neg
af
cultur
neg
pcresim
iqr
ngml
vs
iqr
iqr
ngml
respect
p
howev
median
af
concentr
significantli
higher
patient
without
miac
af
cultur
pcresim
patient
posit
af
cultur
neg
pcresim
figur
differ
median
af
wbc
count
among
four
studi
group
consist
af
differ
median
wbc
count
among
patient
posit
pcresim
gewel
posit
neg
af
cultur
iqr
vs
iqr
cellmm
median
af
wbc
count
among
two
studi
group
significantli
greater
median
af
wbc
count
two
studi
group
neg
pcresim
gewel
irrespect
af
cultur
result
p
figur
differ
median
af
wbc
concentr
among
four
studi
group
consist
direct
statist
signific
fit
quantil
regress
model
adjust
potenti
confound
includ
gestat
age
cervic
dilat
amniocentesi
data
shown
figur
show
preval
intraamniot
inflamm
ngml
combin
result
af
cultur
pcresim
intraamniot
inflamm
diagnos
patient
posit
af
cultur
posit
pcresim
gewel
result
respect
patient
accordingli
intraamniot
infect
ie
miac
intraamniot
inflamm
one
particip
posit
pcresim
gewel
neg
af
cultur
intraamniot
inflamm
patient
significantli
like
intraamniot
inflamm
women
neg
test
adjust
gestat
age
cervic
dilat
amniocentesi
odd
ratio
confid
interv
ci
tabl
iii
none
three
women
posit
af
cultur
neg
pcresim
intraamniot
inflamm
importantli
patient
neg
result
test
af
cultur
pcresim
consid
steril
sampl
intraamniot
inflamm
figur
relationship
detect
microorgan
amniot
fluid
acut
histolog
chorioamnion
figur
show
preval
histolog
acut
chorioamnion
among
four
studi
group
accord
result
pcresim
af
cultur
seven
patient
posit
af
cultur
posit
pcresim
result
gewel
histolog
acut
chorioamnion
histolog
acut
chorioamnion
diagnos
patient
posit
pcresim
gewel
neg
af
cultur
patient
significantli
like
acut
histolog
chorioamnion
women
neg
test
adjust
gestat
age
cervic
dilat
amniocentesi
ci
respect
tabl
iii
one
three
women
posit
af
cultur
neg
pcresim
mild
histolog
acut
chorioamnion
stage
subchorionitischorion
figur
observ
describ
previou
paragraph
combin
paramet
assess
intraamniot
inflamm
reveal
posit
af
cultur
among
patient
neg
pcresim
result
like
reflect
either
earlyphas
microbi
invas
inflammatori
respons
detect
contamin
specimen
falseposit
cultur
tabl
iv
present
posit
predict
valu
ppv
af
cultur
posit
pcresim
gewel
identif
patient
deliv
spontan
prior
week
respect
ppv
posit
af
cultur
spontan
deliveri
week
respect
contrast
ppv
posit
pcresim
gewel
outcom
similarli
ppv
posit
pcresim
gewel
posit
af
cultur
identif
patient
deliv
within
day
amniocentesi
respect
tabl
iv
kaplanmei
surviv
estim
censor
subject
labor
induc
matern
fetal
indic
show
amniocentesistodeliveri
interv
significantli
shorter
patient
posit
pcresim
result
gewel
neg
af
cultur
patient
neg
result
test
iqr
day
vs
iqr
day
signific
differ
median
amniocentesistodeliveri
interv
patient
posit
pcresim
gewel
neg
af
cultur
iqr
day
patient
posit
find
test
iqr
day
figur
figur
show
forest
plot
hazard
ratio
hr
describ
rel
risk
spontan
preterm
deliveri
sptd
patient
posit
pcresim
ge
well
andor
af
cultur
compar
neg
test
adjust
gestat
age
amniocentesi
cervic
dilat
risk
ie
hazard
sptd
week
separ
week
significantli
greater
among
patient
posit
pcresim
result
gewel
without
posit
af
cultur
compar
women
neg
test
sptd
af
hr
ci
af
hr
ci
sptd
af
hr
ci
af
hr
ci
preval
perinat
death
fetal
neonat
death
differ
significantli
among
four
studi
group
defin
result
af
cultur
pcresim
figur
twenti
percent
perinat
death
occur
women
posit
pcresim
neg
af
cultur
result
offspr
women
fivefold
greater
risk
perinat
mortal
women
neg
af
cultur
neg
pcresim
result
ci
differ
rate
perinat
death
offspr
women
posit
pcresim
accord
result
af
cultur
posit
cultur
vs
neg
cultur
princip
find
preval
miac
patient
preterm
labor
intact
membran
use
standard
cultiv
techniqu
use
pcresim
patient
posit
pcresim
gewel
neg
af
cultur
higher
rate
intraamniot
inflamm
histolog
acut
chorioamnion
shorter
interv
deliveri
offspr
greater
risk
perinat
mortal
patient
neg
result
test
differ
factor
compar
patient
posit
pcresim
ge
well
posit
neg
af
cultur
genom
materi
virus
af
detect
two
patient
taken
togeth
find
strongli
suggest
pcresim
use
rapid
test
diagnos
miac
guid
patient
manag
key
transit
human
life
emerg
steril
nonsteril
environ
time
birth
amniot
fluid
steril
normal
circumst
upon
conduct
systemat
investig
use
cultiv
molecular
techniqu
found
overwhelm
major
women
normal
pregnanc
outcom
evid
bacteria
virus
amniot
caviti
contrast
patient
preterm
labor
intact
membran
deliv
preterm
evid
miac
wherea
women
prelabor
ruptur
membran
prom
miac
preval
miac
patient
prom
function
obstetr
circumst
prompt
investig
microbi
state
amniot
caviti
exampl
earlier
gestat
age
present
preterm
labor
preterm
prom
higher
frequenc
miac
importantli
patient
admit
prom
frequenc
miac
increas
without
labor
onset
spontan
preterm
labor
uniqu
data
obtain
routin
administr
antibiot
patient
preterm
prom
basi
clinic
dogma
onset
labor
women
frequent
due
subclin
intraamniot
infect
use
cultiv
techniqu
miac
identifi
sever
obstetr
disord
preval
rang
patient
preterm
labor
intact
membran
high
pregnant
women
diagnos
acut
cervic
insuffici
tabl
v
cultivationbas
studi
provid
strong
evid
involv
microorgan
multipl
pregnanc
complic
yet
cultiv
techniqu
repres
minimum
estim
preval
miac
advantag
molecular
techniqu
identif
microorgan
molecular
test
detect
microorgan
consid
diagnost
tool
new
millennium
us
alon
million
case
infecti
diseaserel
ill
report
annual
mani
consid
undiagnos
accordingli
applic
tool
acut
care
set
major
emphasi
context
pregnanc
identif
cultur
bacteria
af
consid
gold
standard
diagnosi
miac
howev
success
cultiv
organ
requir
knowledg
condit
necessari
support
growth
specif
microorgan
often
condit
unknown
render
standard
techniqu
inadequ
detect
mani
organ
implic
human
diseas
exampl
treponema
pallidum
organ
respons
syphili
remain
difficult
cultur
decad
addit
cultiv
method
frequent
unreli
prone
falseneg
result
antibiot
administ
biolog
fluid
obtain
cultur
moreov
result
gener
take
day
often
avail
time
inform
clinic
decis
eg
antibiot
administr
physician
adopt
standard
approach
begin
intraven
antibiot
therapi
without
know
etiolog
agent
respons
suspect
infect
realiz
small
fraction
microbi
world
readili
cultur
clinic
laboratori
prompt
develop
pcrbase
diagnost
techniqu
infecti
diseas
advantag
molecular
techniqu
allow
broadspectrum
microbi
detect
evalu
emerg
novel
infect
assess
antimicrobi
resist
profil
virul
factor
rel
low
cost
method
use
identifi
agent
respons
multipl
condit
previous
consid
unknown
etiolog
eg
tropheryma
whipplei
agent
whippl
diseas
mycobacterium
genavens
caus
dissemin
infect
aid
patient
ehrlichia
chaffeensi
agent
human
tickborn
monocyt
ehrlichiosi
bartonella
hensela
agent
trench
fever
howev
implement
pcr
techniqu
clinic
practic
easi
bacteria
virus
fungi
must
investig
use
separ
assay
time
requir
obtain
result
longer
use
emerg
techniqu
pcresim
broadrang
pcr
method
detect
bacteria
base
fundament
premis
rrna
gene
evolutionarili
conserv
exclus
bacteri
speci
detect
gene
steril
biolog
fluid
amniot
fluid
accordingli
indic
presenc
bacteria
approach
use
mani
investig
identifi
bacteria
amniot
fluid
use
speciesspecif
broadrang
pcr
studi
shown
broadrang
pcr
assay
specif
assay
superior
cultur
detect
microorgan
amniot
fluid
yet
recent
techniqu
remain
research
procedur
time
requir
obtain
result
preclud
use
point
care
test
fundament
advantag
pcresim
technolog
convent
pcr
method
use
broad
primer
mass
spectrometri
allow
rapid
identif
organ
pcresim
result
obtain
within
hour
key
featur
sinc
failur
identifi
pathogen
time
inform
clinic
decis
major
impedi
treatment
infecti
diseas
pcresim
system
also
abl
quantifi
amount
genom
materi
present
biolog
sampl
genom
quantif
use
clinic
circumst
includ
select
antimicrobi
agent
monitor
therapeut
benefit
also
use
select
rout
deliveri
vagin
vs
cesarean
deliveri
case
hiv
infect
exampl
approach
valuabl
includ
viscer
leishmaniasi
infecti
mononucleosi
mortal
risk
assess
patient
pneumococc
pneumonia
pcresim
technolog
also
use
concept
triangul
distinguish
among
microorgan
term
refer
take
measur
multipl
loci
distribut
across
microbi
genom
subsequ
esim
use
rapidli
determin
precis
masstocharg
ratio
fragment
amplifi
base
upon
nucleotid
composit
creat
signatur
allow
identif
larg
number
microorgan
genu
speci
level
identif
bacteria
amniot
fluid
patholog
find
defin
microbi
invas
amniot
caviti
distinct
invas
infect
predic
host
respons
invad
microorgan
thu
intraamniot
infect
refer
combin
miac
intraamniot
inflamm
studi
miac
diagnos
pcr
esim
studi
popul
patient
exhibit
host
inflammatori
respons
consist
intraamniot
infect
af
ngml
contrast
patient
posit
amniot
fluid
cultur
host
respons
although
seven
case
test
posit
met
criteria
intraamniot
infect
accordingli
use
pcresim
result
twofold
greater
preval
intraamniot
infect
vs
role
viral
infect
spontan
preterm
labor
examin
rigor
previou
studi
use
pcrbase
method
shown
conflict
result
describ
preval
viral
invas
amniot
caviti
viac
rang
nondetect
high
studi
use
pcresim
detect
multipl
organ
sampl
virus
bacteria
coinfect
may
occur
howev
two
patient
posit
result
enteroviru
recent
gervasi
et
al
use
specif
pcr
assay
panel
virus
report
preval
viac
second
trimest
studi
gervasi
et
al
collect
amniot
fluid
sampl
asymptomat
patient
second
trimest
presenc
viral
nucleic
acid
af
associ
detect
inflamm
reflect
af
wbc
count
glucos
concentr
patient
without
viac
similarli
baschat
et
al
suggest
isol
virus
amniot
caviti
associ
advers
matern
perinat
outcom
recent
studi
suggest
system
viral
infect
may
predispos
pregnant
mice
effect
microbi
product
endotoxin
specif
pregnant
mice
infect
herpesviru
like
spontan
preterm
labor
deliv
follow
endotoxin
administr
expos
viru
studi
requir
determin
mechan
diseas
oper
human
well
known
viral
infect
respiratori
tract
predispos
bacteri
infect
pneumonia
may
case
lower
genit
tract
howev
viral
infect
system
associ
symptomat
state
local
uterin
cervix
part
genit
tract
identif
subclin
infect
would
pose
import
challeng
yet
given
high
preval
divers
virus
well
sever
consequ
viral
predisposit
bacteri
infect
possibl
ignor
challeng
interpret
result
molecular
microbiolog
techniqu
differenti
truefrom
falseposit
result
pcr
method
amplifi
extrem
small
quantiti
microbi
dna
contamin
specimen
may
appear
posit
result
studi
use
host
respons
microbi
invas
eg
intraamniot
inflamm
histolog
acut
chorioamnion
onset
spontan
preterm
deliveri
assess
clinic
signific
microbi
detect
pcresim
found
microbi
burden
express
gene
copieswel
significantli
correl
marker
intraamniot
inflamm
even
exclud
patient
posit
amniot
fluid
cultur
preval
intraamniot
inflamm
histolog
acut
chorioamnion
patient
neg
cultur
posit
pcresim
respect
patient
posit
pcresim
result
neg
amniot
fluid
cultur
also
significantli
shorter
interv
spontan
preterm
deliveri
women
neg
test
moreov
neonat
born
mother
posit
pcresim
neg
amniot
fluid
cultur
fivefold
greater
risk
perinat
mortal
born
mother
neg
test
togeth
find
strongli
support
conclus
posit
pcresim
gewel
result
repres
true
posit
find
even
amniot
fluid
cultur
neg
bacteri
cultur
consid
sensit
test
identif
microorgan
condit
support
growth
particular
microorgan
optim
even
one
organ
form
coloni
cultur
ideal
circumst
yet
one
organ
may
insuffici
detect
use
pcr
method
previou
studi
identifi
patient
posit
amniot
fluid
cultur
neg
pcr
use
broad
primer
specif
assay
result
attribut
possibl
dna
degrad
low
inoculum
size
etc
observ
herein
suggest
fals
neg
pcresim
result
extrem
rare
phenomenon
none
three
patient
posit
amniot
fluid
cultur
neg
pcresim
result
studi
intraamniot
inflamm
one
mild
histolog
acut
chorionitissubchorion
three
deliv
week
gestat
without
major
complic
accordingli
doubt
posit
amniot
fluid
cultur
neg
pcresim
result
constitut
trueposit
cultur
acidovorax
sp
identifi
pcresim
one
patient
neg
amniot
fluid
cultur
microbi
burden
case
low
gewel
amniot
fluid
gram
stain
neg
evid
intraamniot
infect
amniot
fluid
glucos
wbc
count
histolog
acut
chorioamnion
yet
patient
deliv
th
week
gestat
acidovorax
sp
identifi
contamin
studi
thu
unlik
pcresim
identifi
true
infect
respons
process
led
preterm
deliveri
preterm
labor
case
like
attribut
mechan
intraamniot
infect
studi
necessari
investig
frequenc
fals
posit
neg
pcresim
result
use
fresh
sampl
collect
clinic
set
therapi
reduc
rate
preterm
birth
patient
symptom
preterm
labor
focus
almost
exclus
tocolyt
agent
howev
effort
limit
success
partli
attribut
syndrom
natur
preterm
labor
may
requir
etiologybas
approach
diagnosi
treatment
prevent
miac
subclin
intraamniot
inflamm
implic
least
onethird
case
spontan
preterm
labor
deliveri
furthermor
intraamniot
infect
recogn
predispos
cerebr
palsi
chronic
lung
diseas
howev
except
asymptomat
bacteriuria
prophylact
antibiot
treatment
success
prevent
preterm
birth
claim
may
increas
rate
preterm
deliveri
ineffect
antibiot
attribut
inclus
random
clinic
trial
patient
evid
infect
therefor
benefit
antimicrobi
therapi
choic
time
antimicrobi
agent
presenc
biofilm
bacteria
refractori
antimicrobi
treatment
etc
benefit
antimicrobi
treatment
could
includ
erad
intraamniot
infect
earli
phase
regul
inflammatori
cascad
lead
preterm
labor
deliveri
prevent
exagger
inflammatori
respons
syndrom
may
caus
fetal
injuri
even
congenit
neonat
sepsi
anim
model
intraamniot
infect
shown
earli
administr
antibiot
within
hour
inocul
bacteria
af
reduc
bacteri
burden
blood
peritoneum
uteru
amniot
fluid
moreov
grigsbi
et
al
shown
anim
model
intraamniot
infect
gener
inocul
ureaplasma
parvum
administr
specif
matern
antibiot
therapi
azithromycin
erad
ureaplasma
parvum
amniot
fluid
fetal
lung
prolong
pregnanc
erad
miac
parenter
antibiot
also
document
patient
short
cervix
well
patient
preterm
labor
exampl
hassan
et
al
report
patient
short
cervix
posit
af
cultur
ureaplasma
urealyticum
af
cultur
steril
follow
day
intraven
azithromycin
three
four
case
deliv
term
rapid
highthroughput
techniqu
use
studi
promis
option
facilit
broader
faster
identif
miac
patient
preterm
labor
intact
membran
applic
complic
pregnanc
accordingli
techniqu
may
render
standard
cultiv
method
limit
valu
would
allow
target
specif
intervent
risk
patient
includ
hospit
deliveri
transfer
high
level
facil
special
neonat
care
futur
studi
requir
clarifi
whether
time
administr
specif
antibiot
therapi
intraamniot
infect
could
improv
perinat
outcom
yet
note
previous
group
studi
may
difficult
conduct
current
framework
regul
protect
human
subject
research
risk
sinc
withhold
antimicrobi
therapi
immunecompromis
patient
human
fetu
would
like
ethic
unaccept
first
report
use
pcresim
amniot
fluid
patient
ptl
intact
membran
well
first
direct
comparison
technolog
standard
cultiv
techniqu
result
provid
evid
import
number
genom
copi
bacteria
intraamniot
infect
futur
studi
requir
assess
perform
pcresim
freshli
collect
sampl
rapid
diagnosi
intraamniot
infect
possibl
use
pcresim
provid
result
within
hour
combin
use
biomark
inflamm
pcresim
allow
rapid
identif
specif
bacteria
case
preterm
labor
intraamniot
inflamm
approach
may
allow
administr
time
specif
intervent
reduc
morbid
attribut
infectioninduc
preterm
birth
gravett
amniot
fluid
inflammatori
profil
deliveri
inform
placenta
patholog
perinat
mortal
patient
microbi
invas
amniot
caviti
accord
amniot
fluid
cultur
vs
gewel
result
use
pcresim
histolog
